VEGFA and neoplasm: Pre-clinical data have shown that shutting down tumor vasculature via acute inhibition of vascular endothelial growth factor A signal transduction in mice bearing PC-3 human prostate adenocarcinoma xenografts leads to a reduction in the tumor Ktrans values [58].